Evommune, Inc. is a biotechnology company focused on developing treatments for chronic inflammatory diseases.

Cercle is an AI-driven company that transforms de-identified healthcare data into actionable insights for women's healthcare providers.

AOA Dx is a NYC-based company that has raised $17M in funding to develop a detection test for ovarian cancer using their GlycoLocate™ platform, which focuses on glycolipids and tumor marker gangliosides to improve early cancer detection.